Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Association between exhaled nitric oxide and nasal polyposis in severe asthma.

Maniscalco M, Calabrese C, D'Amato M, Guida P, Molino A, Aliani M, De Tullio R, Foschino Barbaro M, Ricciardolo FLM, Carpagnano GE.

Respir Med. 2019 Jun;152:20-24. doi: 10.1016/j.rmed.2019.04.017. Epub 2019 Apr 25.

PMID:
31128605
2.

Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab.

Carpagnano GE, Scioscia G, Lacedonia D, Curradi G, Foschino Barbaro MP.

J Asthma Allergy. 2019 Mar 5;12:83-90. doi: 10.2147/JAA.S196200. eCollection 2019.

3.

Application of machine learning to predict obstructive sleep apnea syndrome severity.

Mencar C, Gallo C, Mantero M, Tarsia P, Carpagnano GE, Foschino Barbaro MP, Lacedonia D.

Health Informatics J. 2019 Jan 30:1460458218824725. doi: 10.1177/1460458218824725. [Epub ahead of print]

PMID:
30696334
4.

A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy.

Carpagnano GE, Susca A, Scioscia G, Lacedonia D, Cotugno G, Soccio P, Santamaria S, Resta O, Logrieco G, Foschino Barbaro MP.

BMC Infect Dis. 2019 Jan 22;19(1):78. doi: 10.1186/s12879-019-3718-8.

5.

MicroRNA expression profile during different conditions of hypoxia.

Lacedonia D, Scioscia G, Pia Palladino G, Gallo C, Carpagnano GE, Sabato R, Foschino Barbaro MP.

Oncotarget. 2018 Oct 12;9(80):35114-35122. doi: 10.18632/oncotarget.26210. eCollection 2018 Oct 12.

6.

Looking for Airways Periostin in Severe Asthma: Could It Be Useful for Clustering Type 2 Endotype?

Carpagnano GE, Scioscia G, Lacedonia D, Soccio P, Lepore G, Saetta M, Foschino Barbaro MP, Barnes PJ.

Chest. 2018 Nov;154(5):1083-1090. doi: 10.1016/j.chest.2018.08.1032. Epub 2018 Oct 15.

PMID:
30336944
7.

Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension.

Carpagnano GE, Radaeli A, Lacedonia D, Correale M, Carpagnano G, Palmiotti A, Barbaro MPF, Di Biase M, Brunetti N, Scioscia G, Malerba M.

Biomed Res Int. 2018 Aug 26;2018:7292045. doi: 10.1155/2018/7292045. eCollection 2018.

8.

Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome.

Lacedonia D, Carpagnano GE, Patricelli G, Carone M, Gallo C, Caccavo I, Sabato R, Depalo A, Aliani M, Capozzolo A, Foschino Barbaro MP.

Clin Respir J. 2018 May;12(5):1905-1911. doi: 10.1111/crj.12754. Epub 2018 Jan 16.

PMID:
29227046
9.

New non invasive ventilator strategy applied to COPD patients in acute ventilator failure.

Carpagnano GE, Sabato R, Lacedonia D, Di Gioia R, Saliani V, Vincenzi U, Foschino-Barbaro MP.

Pulm Pharmacol Ther. 2017 Oct;46:64-68. doi: 10.1016/j.pupt.2017.08.009. Epub 2017 Aug 17.

PMID:
28823948
10.

Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects.

Malerba M, Radaeli A, Nardin M, Clini E, Carpagnano GE, Sciatti E, Salghetti F, Bonadei I, Platto F, Vizzardi E.

Clin Respir J. 2018 Apr;12(4):1466-1472. doi: 10.1111/crj.12686. Epub 2017 Aug 16.

PMID:
28779547
11.

Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.

Lacedonia D, Palladino GP, Foschino-Barbaro MP, Scioscia G, Carpagnano GE.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 23;12:1811-1817. doi: 10.2147/COPD.S130616. eCollection 2017.

12.

The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients.

Malerba M, Nardin M, Radaeli A, Montuschi P, Carpagnano GE, Clini E.

Expert Rev Hematol. 2017 Sep;10(9):821-832. doi: 10.1080/17474086.2017.1353416. Epub 2017 Jul 12. Review.

PMID:
28693343
13.

A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis.

Carpagnano GE, Santacroce R, Palmiotti GA, Leccese A, Giuffreda E, Margaglione M, Foschino Barbaro MP, Aliberti S, Lacedonia D.

Lung. 2017 Oct;195(5):679-682. doi: 10.1007/s00408-017-0033-2. Epub 2017 Jul 1.

PMID:
28668972
14.

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, Boots AW, Bos LD, Brinkman P, Bucca C, Carpagnano GE, Corradi M, Cristescu S, de Jongste JC, Dinh-Xuan AT, Dompeling E, Fens N, Fowler S, Hohlfeld JM, Holz O, Jöbsis Q, Van De Kant K, Knobel HH, Kostikas K, Lehtimäki L, Lundberg J, Montuschi P, Van Muylem A, Pennazza G, Reinhold P, Ricciardolo FLM, Rosias P, Santonico M, van der Schee MP, van Schooten FJ, Spanevello A, Tonia T, Vink TJ.

Eur Respir J. 2017 Apr 26;49(4). pii: 1600965. doi: 10.1183/13993003.00965-2016. Print 2017 Apr.

15.

Exhaled breath temperature measurement: influence of circadian rhythm.

Carpagnano GE, Lacedonia D, Malerba M, Martinelli D, Cotugno G, Foschino-Barbaro MP.

J Biol Regul Homeost Agents. 2017 Jan-Mar;31(1):229-235.

PMID:
28337897
16.

Respiratory drive in patients with chronic heart failure and central sleep apnea: Data from the Daunia Heart Failure Registry.

Correale M, Carpagnano GE, Brunetti ND, Forte L, Monaco I, Ferraretti A, Sabato R, Barbaro MP, Di Biase M, Lacedonia D.

Int J Cardiol. 2017 Mar 1;230:630-633. doi: 10.1016/j.ijcard.2016.12.172. Epub 2016 Dec 27. No abstract available.

PMID:
28065692
17.

New panel of microsatellite alterations detectable in the EBC for lung cancer prognosis.

Carpagnano GE, Lacedonia D, Crisetti E, Martinelli D, Foschino-Barbaro MP.

J Cancer. 2016 Nov 25;7(15):2266-2269. eCollection 2016.

18.

Validation of the Exhaled Breath Temperature Measure: Reference Values in Healthy Subjects.

Carpagnano GE, Foschino-Barbaro MP, Crocetta C, Lacedonia D, Saliani V, Zoppo LD, Barnes PJ.

Chest. 2017 Apr;151(4):855-860. doi: 10.1016/j.chest.2016.11.013. Epub 2016 Nov 23.

PMID:
27889360
19.

Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.

Sposato B, Scalese M, Latorre M, Scichilone N, Matucci A, Milanese M, Masieri S, Rolla G, Steinhilber G, Rosati Y, Vultaggio A, Folletti I, Baglioni S, Bargagli E, Di Tomassi M, Pio R, Pio A, Maccari U, Maggiorelli C, Migliorini MG, Vignale L, Pulerà N, Carpagnano GE, Foschino Barbaro MP, Perrella A, Paggiaro PL.

Respir Med. 2016 Oct;119:141-149. doi: 10.1016/j.rmed.2016.09.005. Epub 2016 Sep 4.

20.

How strong is the association between IPF and lung cancer? An answer from airway's DNA.

Carpagnano GE, Lacedonia D, Soccio P, Caccavo I, Patricelli G, Foschino Barbaro MP.

Med Oncol. 2016 Nov;33(11):119. doi: 10.1007/s12032-016-0835-8. Epub 2016 Sep 29.

PMID:
27688240
21.

Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease.

Dragonieri S, Quaranta VN, Carratu P, Lacedonia D, Carpagnano GE, Milano A, D'Alba G, Ranieri T, Barbaro MP, Resta O.

Lung India. 2016 Sep-Oct;33(5):579-80. doi: 10.4103/0970-2113.189000. No abstract available.

22.

Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome.

Lacedonia D, Nigro E, Matera MG, Scudiero O, Monaco ML, Polito R, Carpagnano GE, Foschino Barbaro MP, Mazzarella G, Bianco A, Daniele A.

Pulm Pharmacol Ther. 2016 Oct;40:104-8. doi: 10.1016/j.pupt.2016.07.008. Epub 2016 Jul 25.

PMID:
27470682
23.

Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma?

Calabrese C, Carpagnano GE, Patella V, Vatrella A, Santus P.

Minerva Med. 2015 Oct;106(5 Suppl 1):9-11.

24.

Viral colonization in exhaled breath condensate of lung cancer patients: Possible role of EBV and CMV.

Carpagnano GE, Lacedonia D, Natalicchio MI, Cotugno G, Zoppo L, Martinelli D, Antonetti R, Foschino-Barbaro MP.

Clin Respir J. 2018 Feb;12(2):418-424. doi: 10.1111/crj.12531. Epub 2016 Jul 25.

PMID:
27421948
25.

Characterization of obstructive sleep apnea-hypopnea syndrome (OSA) population by means of cluster analysis.

Lacedonia D, Carpagnano GE, Sabato R, Storto MM, Palmiotti GA, Capozzi V, Barbaro MP, Gallo C.

J Sleep Res. 2016 Dec;25(6):724-730. doi: 10.1111/jsr.12429. Epub 2016 May 18.

26.

Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma.

Carpagnano GE, Malerba M, Lacedonia D, Susca A, Logrieco A, Carone M, Cotugno G, Palmiotti GA, Foschino-Barbaro MP.

Allergy Asthma Proc. 2016 May;37(3):41-6. doi: 10.2500/aap.2016.37.3943.

PMID:
27178886
27.

Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases.

Carpagnano GE, Lacedonia D, Carone M, Soccio P, Cotugno G, Palmiotti GA, Scioscia G, Foschino Barbaro MP.

J Breath Res. 2016 Apr 11;10(2):026005. doi: 10.1088/1752-7155/10/2/026005.

PMID:
27063576
28.

Microparticles in sputum of COPD patients: a potential biomarker of the disease?

Lacedonia D, Carpagnano GE, Trotta T, Palladino GP, Panaro MA, Zoppo LD, Foschino Barbaro MP, Porro C.

Int J Chron Obstruct Pulmon Dis. 2016 Mar 14;11:527-33. doi: 10.2147/COPD.S99547. eCollection 2016.

29.

Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking?

Carpagnano GE, Ruggieri C, Scioscia G, Storto MM, Zoppo L, Foschino-Barbaro MP.

COPD. 2016 Oct;13(5):642-6. doi: 10.3109/15412555.2016.1143458. Epub 2016 Mar 2.

PMID:
26934668
30.

Analysis of mitochondrial DNA alteration in new phenotype ACOS.

Carpagnano GE, Lacedonia D, Malerba M, Palmiotti GA, Cotugno G, Carone M, Foschino-Barbaro MP.

BMC Pulm Med. 2016 Feb 12;16:31. doi: 10.1186/s12890-016-0192-6.

31.

Big atria, little P waves: unexpected mismatch between chamber volume and electrocardiogram signal in "false" atrial fibrillation.

Carpagnano G, Ieva R, Correale M, Di Biase M, Brunetti ND.

Am J Emerg Med. 2016 Aug;34(8):1740.e1-2. doi: 10.1016/j.ajem.2016.01.001. Epub 2016 Jan 7. No abstract available.

PMID:
26847156
32.

VIP: A New Promising Marker for AECOPD--A Fashionable Marker Soon Forgotten?

Carpagnano GE, Pelaia G.

Respiration. 2015;90(5):353-4. doi: 10.1159/000441307. Epub 2015 Oct 20. No abstract available.

33.

Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma.

Calabrese C, Carpagnano GE, Patella V, Vatrella A, Santus P.

Minerva Med. 2015 Nov 19. [Epub ahead of print]

PMID:
26583284
34.

Values in Elderly People for Exhaled Nitric Oxide Study.

Malerba M, Damiani G, Carpagnano GE, Olivini A, Radaeli A, Ragnoli B, Foschino MP, Olivieri M.

Rejuvenation Res. 2016 Jun;19(3):233-8. doi: 10.1089/rej.2015.1706. Epub 2016 Feb 23.

PMID:
26414479
35.

Tissue Doppler Imaging predicts central sleep apnea in patients with chronic heart failure: data from the Daunia Registry.

Correale M, Brunetti ND, Forte L, Passero T, Monaco I, Ferraretti A, Totaro A, Carpagnano GE, Foschino Barbaro MP, Di Biase M, Lacedonia D.

Eur J Clin Invest. 2015 Nov;45(11):1153-60. doi: 10.1111/eci.12520. Epub 2015 Sep 13.

PMID:
26365893
36.

Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation?

Carpagnano GE, Lacedonia D, Spanevello A, Cotugno G, Saliani V, Martinelli D, Foschino-Barbaro MP.

Med Oncol. 2015 Oct;32(10):237. doi: 10.1007/s12032-015-0681-0. Epub 2015 Sep 1.

PMID:
26323590
37.

Mitochondrial DNA alteration in obstructive sleep apnea.

Lacedonia D, Carpagnano GE, Crisetti E, Cotugno G, Palladino GP, Patricelli G, Sabato R, Foschino Barbaro MP.

Respir Res. 2015 Apr 7;16:47. doi: 10.1186/s12931-015-0205-7.

38.

Exhaled HPV infection in lung cancer: role of MA at 3p.

Carpagnano GE, Lacedonia D, Crisetti E, Palladino GP, Saliani V, Zoppo LD, Antonetti R, Natalicchio I, Foschino-Barbaro MP.

Arch Med Res. 2014 Jul;45(5):383-7. doi: 10.1016/j.arcmed.2014.06.006. Epub 2014 Jun 21.

PMID:
24962429
39.

Exhaled breath temperature in NSCLC: could be a new non-invasive marker?

Carpagnano GE, Lacedonia D, Spanevello A, Martinelli D, Saliani V, Ruggieri C, Foschino-Barbaro MP.

Med Oncol. 2014 May;31(5):952. doi: 10.1007/s12032-014-0952-1. Epub 2014 Apr 11.

PMID:
24722795
40.

Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy.

Carpagnano GE, Lacedonia D, Palladino GP, Logrieco G, Crisetti E, Susca A, Logrieco A, Foschino-Barbaro MP.

BMC Pulm Med. 2014 Feb 18;14:22. doi: 10.1186/1471-2466-14-22.

41.

HPV-associated lung cancers: an international pooled analysis.

Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, Spandidos DA, Gorgoulis V, Heideman DA, van Boerdonk RA, Hiroshima K, Iwakawa R, Kastrinakis NG, Kinoshita I, Akiba S, Landi MT, Eugene Liu H, Wang JL, Mehra R, Khuri FR, Lim WT, Owonikoko TK, Ramalingam S, Sarchianaki E, Syrjanen K, Tsao MS, Sykes J, Hee SW, Yokota J, Zaravinos A, Taioli E.

Carcinogenesis. 2014 Jun;35(6):1267-75. doi: 10.1093/carcin/bgu038. Epub 2014 Feb 12.

42.

Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension.

Lacedonia D, Valerio G, Palladino GP, Carpagnano GE, Correale M, Di Biase M, Foschino Barbaro MP.

Rejuvenation Res. 2014 Feb;17(1):33-9. doi: 10.1089/rej.2013.1478.

PMID:
24228853
43.

Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series.

Santoro F, Ieva R, Ferraretti A, Ienco V, Carpagnano G, Lodispoto M, Di Biase L, Di Biase M, Brunetti ND.

Cardiovasc Ther. 2013 Dec;31(6):e133-7. doi: 10.1111/1755-5922.12047.

PMID:
24119220
44.

Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma.

Barbaro MP, Spanevello A, Palladino GP, Salerno FG, Lacedonia D, Carpagnano GE.

Eur J Intern Med. 2014 Jan;25(1):92-6. doi: 10.1016/j.ejim.2013.08.705. Epub 2013 Sep 23.

PMID:
24070522
45.

Wake-up call by breathomics in sleep apnoea.

Sterk PJ, Fens N, Carpagnano GE.

Eur Respir J. 2013 Jul;42(1):1-4. doi: 10.1183/09031936.00000113. No abstract available.

46.

Aging and airway inflammation.

Carpagnano GE, Turchiarelli V, Spanevello A, Palladino GP, Barbaro MP.

Aging Clin Exp Res. 2013 Jun;25(3):239-45. doi: 10.1007/s40520-013-0040-y. Epub 2013 May 18.

PMID:
23740581
47.

Tako-Tsubo cardiomyopathy after influenza vaccination.

Santoro F, Ieva R, Ferraretti A, Carpagnano G, Pappalardo I, De Gennaro L, Di Biase M, Brunetti ND.

Int J Cardiol. 2013 Jul 31;167(2):e51-2. doi: 10.1016/j.ijcard.2013.03.147. Epub 2013 Apr 20. No abstract available.

PMID:
23608394
48.

Acute renal failure, digoxin toxicity and brady-arrhythmia as possible triggers in Tako-Tsubo cardiomyopathy.

Santoro F, Ieva R, Ferraretti A, Carpagnano G, Lodispoto M, De Gennaro L, Di Biase M, Brunetti ND.

Int J Cardiol. 2013 May 25;165(3):e51-2. doi: 10.1016/j.ijcard.2012.11.015. Epub 2012 Dec 4. No abstract available.

PMID:
23218574
49.

Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome).

Lacedonia D, Carpagnano GE, Aliani M, Sabato R, Foschino Barbaro MP, Spanevello A, Carone M, Fanfulla F.

Respir Med. 2013 Feb;107(2):310-6. doi: 10.1016/j.rmed.2012.10.012. Epub 2012 Nov 7.

50.

Exhaled matrix metalloproteinase-9 in lung cancer.

Carpagnano GE, Palladino GP, Martinelli D, Lacedonia D, Orlando S, Foschino-Barbaro MP.

Rejuvenation Res. 2012 Aug;15(4):359-65. doi: 10.1089/rej.2011.1254.

PMID:
22877564

Supplemental Content

Loading ...
Support Center